Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Combination of HDX-MS and in silico modeling to study enzymatic reactivity and stereo-selectivity at different solvent conditions.

Makarov AA, Iacob RE, Pirrone GF, Rodriguez-Granillo A, Joyce L, Mangion I, Moore JC, Sherer EC, Engen JR.

J Pharm Biomed Anal. 2020 Apr 15;182:113141. doi: 10.1016/j.jpba.2020.113141. Epub 2020 Feb 1.

PMID:
32036298
2.

Design of an in vitro biocatalytic cascade for the manufacture of islatravir.

Huffman MA, Fryszkowska A, Alvizo O, Borra-Garske M, Campos KR, Canada KA, Devine PN, Duan D, Forstater JH, Grosser ST, Halsey HM, Hughes GJ, Jo J, Joyce LA, Kolev JN, Liang J, Maloney KM, Mann BF, Marshall NM, McLaughlin M, Moore JC, Murphy GS, Nawrat CC, Nazor J, Novick S, Patel NR, Rodriguez-Granillo A, Robaire SA, Sherer EC, Truppo MD, Whittaker AM, Verma D, Xiao L, Xu Y, Yang H.

Science. 2019 Dec 6;366(6470):1255-1259. doi: 10.1126/science.aay8484.

PMID:
31806816
3.

One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers Study.

Rodriguez AE, Larribau M, Fernandez-Pereira C, Iravedra J, Santaera O, Haiek C, Lloberas J, Montoya M, Sisu E, Menendez M, Pavlovsky H, Rodriguez-Granillo AM, Mieres J, Romero G, Ming Z, Pan W, Antoniucci D.

Clin Med Insights Cardiol. 2019 Jun 27;13:1179546819854059. doi: 10.1177/1179546819854059. eCollection 2019.

4.

Late Mortality After Drug-Eluting, Bare-Metal Stents, and Coronary Bypass Surgery in Left Main Disease.

Pavlovsky H, Rodriguez-Granillo AM, Rodriguez AE.

J Am Coll Cardiol. 2019 Apr 9;73(13):1737. doi: 10.1016/j.jacc.2018.12.080. No abstract available.

PMID:
30947932
5.

"Site and Mutation"-Specific Predictions Enable Minimal Directed Evolution Libraries.

Moore JC, Rodriguez-Granillo A, Crespo A, Govindarajan S, Welch M, Hiraga K, Lexa K, Marshall N, Truppo MD.

ACS Synth Biol. 2018 Jul 20;7(7):1730-1741. doi: 10.1021/acssynbio.7b00359. Epub 2018 Jun 12.

PMID:
29782150
6.

Lowering risk score profile during PCI in multiple vessel disease is associated with low adverse events: The ERACI risk score.

Rodriguez AE, Fernandez-Pereira C, Mieres J, Pavlovsky H, Del Pozo J, Rodriguez-Granillo AM, Antoniucci D.

Cardiovasc Revasc Med. 2018 Oct;19(7 Pt A):792-794. doi: 10.1016/j.carrev.2018.01.012. Epub 2018 Feb 13. Review.

PMID:
29519729
7.

Identification of ortho-Substituted Benzoic Acid/Ester Derivatives via the Gas-Phase Neighboring Group Participation Effect in (+)-ESI High Resolution Mass Spectrometry.

Blincoe WD, Rodriguez-Granillo A, Saurí J, Pierson NA, Joyce LA, Mangion I, Sheng H.

J Am Soc Mass Spectrom. 2018 Apr;29(4):694-703. doi: 10.1007/s13361-017-1884-8. Epub 2018 Feb 27.

PMID:
29488104
8.

Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis.

Rodriguez AE, Rodriguez-Granillo AM, Ascarrunz SD, Peralta-Bazan F, Cho MY.

Curr Pharm Des. 2018;24(4):465-477. doi: 10.2174/1381612824666180108121834. Review.

PMID:
29308737
9.

Quantum-Mechanics Methodologies in Drug Discovery: Applications of Docking and Scoring in Lead Optimization.

Crespo A, Rodriguez-Granillo A, Lim VT.

Curr Top Med Chem. 2017;17(23):2663-2680. doi: 10.2174/1568026617666170707120609. Review.

PMID:
28685695
10.

Second vs. first-generation drug-eluting stents in complex lesions subsets: 3 years' follow-up of ERACI IV study.

Rodriguez AE, Santaera O, Larribau M, Sarmiento R, Haiek C, Del Pozo JF, Pavlovsky H, Rodriguez-Granillo AM; ERACI IV Investigators.

Minerva Cardioangiol. 2017 Feb;65(1):81-90. doi: 10.23736/S0026-4725.16.04252-3. Epub 2016 Oct 21.

PMID:
27784884
11.

Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.

Charytan DM, Desai M, Mathur M, Stern NM, Brooks MM, Krzych LJ, Schuler GC, Kaehler J, Rodriguez-Granillo AM, Hueb W, Reeves BC, Thiele H, Rodriguez AE, Buszman PP, Buszman PE, Maurer R, Winkelmayer WC.

Kidney Int. 2016 Aug;90(2):411-421. doi: 10.1016/j.kint.2016.03.033. Epub 2016 Jun 1. Review. Erratum in: Kidney Int. 2017 Mar;91(3):758.

12.

Ventricular Septal Perforation after Biventricular Takotsubo Cardiomyopathy Successfully Repaired with an Amplatzer Device: First Report in the Literature.

Rodríguez AE, Fernandez-Pereira C, Mieres J, Ascarrunz D, Gabe E, Rodríguez-Granillo AM, Frattini R, Stuzbach P.

Case Rep Cardiol. 2016;2016:3251032. doi: 10.1155/2016/3251032. Epub 2016 Apr 13.

13.

Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry.

Haiek C, Fernández-Pereira C, Santaera O, Mieres J, Rifourcat I, Lloberas J, Larribau M, Pocoví A, Rodriguez-Granillo AM, Sarmiento RA, Antoniucci D, Rodriguez AE.

Catheter Cardiovasc Interv. 2017 Jan;89(1):37-46. doi: 10.1002/ccd.26468. Epub 2016 Mar 7.

PMID:
26947138
14.

Structural principles for computational and de novo design of 4Fe-4S metalloproteins.

Nanda V, Senn S, Pike DH, Rodriguez-Granillo A, Hansen WA, Khare SD, Noy D.

Biochim Biophys Acta. 2016 May;1857(5):531-538. doi: 10.1016/j.bbabio.2015.10.001. Epub 2015 Oct 9. Review.

15.

Comparison of cost-effectiveness of oral rapamycin plus bare-metal stents versus first generation of drug-eluting stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 trial).

Rodriguez AE, Palacios I, Rodriguez-Granillo AM, Mieres JR, Tarragona S, Fernandez-Pereira C, Solorzano L, Pauletto R, Serruys PW, Antoniucci D; ORAR-3 investigators.

Am J Cardiol. 2014 Mar 1;113(5):815-21. doi: 10.1016/j.amjcard.2013.11.033. Epub 2013 Dec 13.

PMID:
24528614
16.

Randomized trials of PCIs versus CABG surgery: why coronary stenting should remain the first choice of revascularization in non-diabetic patients and why the controversy is still present in diabetics.

Rodríguez AE, Arismendi L, Romero G, Rodríguez-Granillo AM.

Expert Rev Cardiovasc Ther. 2014 Mar;12(3):297-309. doi: 10.1586/14779072.2014.882770. Epub 2014 Feb 4.

PMID:
24490769
17.

Changes in the safety paradigm with percutaneous coronary interventions in the modern era: Lessons learned from the ASCERT registry.

Rodríguez AE, Fernández-Pereira C, Rodríguez-Granillo AM.

World J Cardiol. 2012 Aug 26;4(8):242-9. doi: 10.4330/wjc.v4.i8.242.

18.

One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR).

Mieres J, Fernandez-Pereira C, Risau G, Solorzano L, Pauletto R, Rodriguez-Granillo AM, Rubilar B, Stella P, Rodriguez AE.

Cardiovasc Revasc Med. 2012 Sep-Oct;13(5):265-71. doi: 10.1016/j.carrev.2012.06.001. Epub 2012 Jul 15.

PMID:
22796496
19.

Energetic selection of topology in ferredoxins.

Kim JD, Rodriguez-Granillo A, Case DA, Nanda V, Falkowski PG.

PLoS Comput Biol. 2012;8(4):e1002463. doi: 10.1371/journal.pcbi.1002463. Epub 2012 Apr 5.

20.

Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial.

Rodriguez AE, Rodriguez-Granillo AM, Antoniucci D, Mieres J, Fernandez-Pereira C, Rodriguez-Granillo GA, Santaera O, Rubilar B, Palacios IF, Serruys PW; ORAR III Investigators.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):385-94. doi: 10.1002/ccd.23352. Epub 2011 Dec 8.

PMID:
22109997
21.

Computational design of thermostabilizing D-amino acid substitutions.

Rodriguez-Granillo A, Annavarapu S, Zhang L, Koder RL, Nanda V.

J Am Chem Soc. 2011 Nov 23;133(46):18750-9. doi: 10.1021/ja205609c. Epub 2011 Oct 27.

22.

Drug eluting or bare metal stents in cardiac allograft vasculopathy: the role of oral sirolimus.

Mieres J, Fernandez-Pereira C, Rodriguez-Granillo AM, Rodriguez AE.

Catheter Cardiovasc Interv. 2012 Feb 15;79(3):496; author reply 497. doi: 10.1002/ccd.23295. Epub 2011 Dec 16. No abstract available.

PMID:
21805610
23.

Advantages and disadvantages of biodegradable platforms in drug eluting stents.

Rodriguez-Granillo A, Rubilar B, Rodriguez-Granillo G, Rodriguez AE.

World J Cardiol. 2011 Mar 26;3(3):84-92. doi: 10.4330/wjc.v3.i3.84.

24.

Effect of doxycycline on atherosclerosis: from bench to bedside.

Rodriguez-Granillo GA, Rodriguez-Granillo A, Milei J.

Recent Pat Cardiovasc Drug Discov. 2011 Jan;6(1):42-54. Review.

PMID:
21208158
25.

Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.

Rodriguez AE, Vigo CF, Delacasa A, Mieres J, Fernandez-Pereira C, Bernardi V, Bettinoti M, Rodriguez-Granillo AM, Rodriguez-Granillo G, Santaera O, Curotto V, Rubilar B, Tronge J, Palacios IF, Antoniucci D; EUCATAX Investigators.

Catheter Cardiovasc Interv. 2011 Feb 15;77(3):335-42. doi: 10.1002/ccd.22769. Epub 2010 Nov 30.

PMID:
20824769
26.

Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial.

Migliorini A, Stabile A, Rodriguez AE, Gandolfo C, Rodriguez Granillo AM, Valenti R, Parodi G, Neumann FJ, Colombo A, Antoniucci D; JETSTENT Trial Investigators.

J Am Coll Cardiol. 2010 Oct 12;56(16):1298-306. doi: 10.1016/j.jacc.2010.06.011. Epub 2010 Aug 5.

27.

Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study.

Rodriguez AE, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Rodriguez Granillo AM, Rodriguez-Granillo GA, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios IF, Serruys PW; ORAR III Investigators.

EuroIntervention. 2009 Jun;5(2):255-64.

PMID:
20449934
28.

Copper-transfer mechanism from the human chaperone Atox1 to a metal-binding domain of Wilson disease protein.

Rodriguez-Granillo A, Crespo A, Estrin DA, Wittung-Stafshede P.

J Phys Chem B. 2010 Mar 18;114(10):3698-706. doi: 10.1021/jp911208z.

PMID:
20166696
29.

Interdomain interactions modulate collective dynamics of the metal-binding domains in the Wilson disease protein.

Rodriguez-Granillo A, Crespo A, Wittung-Stafshede P.

J Phys Chem B. 2010 Feb 11;114(5):1836-48. doi: 10.1021/jp909450x.

PMID:
20078131
30.

Lysine-60 in copper chaperone Atox1 plays an essential role in adduct formation with a target Wilson disease domain.

Hussain F, Rodriguez-Granillo A, Wittung-Stafshede P.

J Am Chem Soc. 2009 Nov 18;131(45):16371-3. doi: 10.1021/ja9058266.

PMID:
19863064
31.

New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.

Perez G, Rodriguez-Granillo AM, Mieres J, Llaurado C, Rubilar B, Risau G, Fernandez-Pereira C, Rodriguez AE.

J Invasive Cardiol. 2009 Aug;21(8):378-82.

PMID:
19652248
32.

Conformational dynamics of metal-binding domains in Wilson disease protein: molecular insights into selective copper transfer.

Rodriguez-Granillo A, Crespo A, Wittung-Stafshede P.

Biochemistry. 2009 Jun 30;48(25):5849-63. doi: 10.1021/bi900235g.

PMID:
19449859
33.

Tuning of copper-loop flexibility in Bacillus subtilis CopZ copper chaperone: role of conserved residues.

Rodriguez-Granillo A, Wittung-Stafshede P.

J Phys Chem B. 2009 Feb 19;113(7):1919-32. doi: 10.1021/jp807594q.

PMID:
19170606
34.

Differential roles of Met10, Thr11, and Lys60 in structural dynamics of human copper chaperone Atox1.

Rodriguez-Granillo A, Wittung-Stafshede P.

Biochemistry. 2009 Feb 10;48(5):960-72. doi: 10.1021/bi8018652.

PMID:
19146392
35.

Stability and ATP binding of the nucleotide-binding domain of the Wilson disease protein: effect of the common H1069Q mutation.

Rodriguez-Granillo A, Sedlak E, Wittung-Stafshede P.

J Mol Biol. 2008 Nov 28;383(5):1097-111. doi: 10.1016/j.jmb.2008.07.065. Epub 2008 Jul 29.

PMID:
18692069
36.

Structure and dynamics of Cu(I) binding in copper chaperones Atox1 and CopZ: a computer simulation study.

Rodriguez-Granillo A, Wittung-Stafshede P.

J Phys Chem B. 2008 Apr 17;112(15):4583-93. doi: 10.1021/jp711787x. Epub 2008 Mar 25.

PMID:
18361527
37.

Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry.

Rodriguez AE, Maree AO, Mieres J, Berrocal D, Grinfeld L, Fernandez-Pereira C, Curotto V, Rodriguez-Granillo A, O'Neill W, Palacios IF.

Eur Heart J. 2007 Sep;28(17):2118-25. Epub 2007 Jul 25.

PMID:
17656352
38.

Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial.

Rodriguez AE, Grinfeld L, Fernandez-Pereira C, Mieres J, Rodriguez Alemparte M, Berrocal D, Rodriguez-Granillo AM, Vigo CF, Russo Felsen M, O'Neill W, Palacios I.

EuroIntervention. 2006 May;2(1):53-60.

PMID:
19755237
39.

Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study.

Rodriguez AE, Granada JF, Rodriguez-Alemparte M, Vigo CF, Delgado J, Fernandez-Pereira C, Pocovi A, Rodriguez-Granillo AM, Schulz D, Raizner AE, Palacios I, O'Neill W, Kaluza GL, Stone G; ORAR II Investigators.

J Am Coll Cardiol. 2006 Apr 18;47(8):1522-9. Epub 2006 Mar 29.

Supplemental Content

Loading ...
Support Center